AU2620695A - Method of cancer treatment by p53 protein control - Google Patents

Method of cancer treatment by p53 protein control

Info

Publication number: AU2620695A
Authority: AU; Australia
Prior art keywords: cancer treatment; protein control; protein; control; cancer
Prior art date: 1994-05-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU26206/95A

Other versions

AU714209B2 (en

Inventor

Jean-Marie Blanchard

Serge Carillo

Marc Peichaczyk

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aventis Pharma SA

Original Assignee

Aventis Pharma SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-31

Filing date

1995-05-22

Publication date

1995-12-21

1995-05-22 Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA

1995-12-21 Publication of AU2620695A publication Critical patent/AU2620695A/en

1999-12-23 Application granted granted Critical

1999-12-23 Publication of AU714209B2 publication Critical patent/AU714209B2/en

2004-11-25 Assigned to AVENTIS PHARMA S.A. reassignment AVENTIS PHARMA S.A. Request to Amend Deed and Register Assignors: RHONE-POULENC RORER S.A.

2015-05-22 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU26206/95A 1994-05-31 1995-05-22 Method of cancer treatment by p53 protein control Ceased AU714209B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR94/06583		1994-05-31
FR9406583A FR2720277B1 (en)	1994-05-31	1994-05-31	Method of treating cancer by regulating the P53 protein.
PCT/FR1995/000670 WO1995033060A1 (en)	1994-05-31	1995-05-22	Method of cancer treatment by p53 protein control

Publications (2)

Publication Number	Publication Date
AU2620695A true AU2620695A (en)	1995-12-21
AU714209B2 AU714209B2 (en)	1999-12-23

Family

ID=9463670

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU26206/95A Ceased AU714209B2 (en)	1994-05-31	1995-05-22	Method of cancer treatment by p53 protein control

Country Status (8)

Country	Link
EP (1)	EP0763121A1 (en)
JP (1)	JPH10500978A (en)
AU (1)	AU714209B2 (en)
CA (1)	CA2190293C (en)
FI (1)	FI120501B (en)
FR (1)	FR2720277B1 (en)
NO (1)	NO321411B1 (en)
WO (1)	WO1995033060A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19518488C1 (en) *	1995-05-19	1996-10-10	Progen Biotechnik Gmbh	Autoantigen, suitable for determining a tendency to thrombosis
EP0799892A3 (en) *	1996-04-05	1998-08-12	Takeda Chemical Industries, Ltd.	Calpain, its production and use
US6232454B1 (en)	1998-02-27	2001-05-15	Incyte Genomics, Inc.	Human proteinase molecules
AU2344100A (en) *	1998-11-18	2000-06-05	Canji, Inc.	Viral vectors with late transgene expression
AU2001247922A1 (en) *	2000-03-31	2001-10-15	Parker Hughes Institute	Calpain inhibitors in cancer treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0753665B2 (en) *	1984-04-20	1995-06-07	財団法人癌研究会	Anti-metastatic agent
US5340922B1 (en) *	1988-05-31	1999-11-02	Mclean Hospital Corp	Neural calcium-activated neutral proteinase inhibitors
EP0395309B1 (en) *	1989-04-28	1995-12-27	Takara Shuzo Co. Ltd.	Human calpastatin-like polypeptide
JPH0641067A (en) *	1992-04-20	1994-02-15	Kitasato Inst:The	New calpain-inhibitor kp-1241 and its production
EP0580161A1 (en) *	1992-07-22	1994-01-26	THE McLEAN HOSPITAL CORPORATION	Prophylactic and therapeutic treatment of Alzheimer's disease
US5607831A (en) *	1993-03-25	1997-03-04	The United States Of America As Represented By The Department Of Health And Human Services	In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death

1994
- 1994-05-31 FR FR9406583A patent/FR2720277B1/en not_active Expired - Lifetime
1995
- 1995-05-22 AU AU26206/95A patent/AU714209B2/en not_active Ceased
- 1995-05-22 JP JP8500420A patent/JPH10500978A/en active Pending
- 1995-05-22 EP EP95920973A patent/EP0763121A1/en not_active Withdrawn
- 1995-05-22 WO PCT/FR1995/000670 patent/WO1995033060A1/en not_active Application Discontinuation
- 1995-05-22 CA CA2190293A patent/CA2190293C/en not_active Expired - Fee Related
1996
- 1996-11-11 NO NO19964772A patent/NO321411B1/en not_active IP Right Cessation
- 1996-11-29 FI FI964783A patent/FI120501B/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI120501B (en)	2009-11-13
FI964783A0 (en)	1996-11-29
FR2720277A1 (en)	1995-12-01
EP0763121A1 (en)	1997-03-19
CA2190293C (en)	2011-06-28
AU714209B2 (en)	1999-12-23
WO1995033060A1 (en)	1995-12-07
CA2190293A1 (en)	1995-12-07
NO321411B1 (en)	2006-05-08
FI964783L (en)	1996-11-29
JPH10500978A (en)	1998-01-27
FR2720277B1 (en)	1996-07-12
NO964772L (en)	1996-11-11
NO964772D0 (en)	1996-11-11

Publication	Publication Date	Title
AU5268696A (en)	1996-11-07	Novel compounds and methods for therapy
AU4052897A (en)	1998-03-19	Cancer treatment method
AU2092697A (en)	1997-09-22	Combinations for treatment of proliferative diseases
AU657880B1 (en)	1995-03-23	Control method of air-conditioner
AU1771195A (en)	1995-11-09	Method of administering azithromycin
AU6479596A (en)	1997-02-05	Methods for treating diabetes
AU9028798A (en)	1999-03-16	Method of improving drug treatment
AU7905894A (en)	1995-08-03	Treatment of poultry
AUPN271295A0 (en)	1995-05-25	Method of treatment
AUPM761094A0 (en)	1994-09-15	Treatment of hides
AU4776096A (en)	1996-08-21	Whey treatment process
AU6407094A (en)	1994-10-11	Method of treating tumors with antibodies
AU3524995A (en)	1996-04-19	Method for treatment of cancers by regulating the activity of ras proteins
AU7166896A (en)	1997-04-01	Cancer treatment
AU7498296A (en)	1997-05-22	Use of protein gax for treating cancer
AU2620695A (en)	1995-12-21	Method of cancer treatment by p53 protein control
AU1994697A (en)	1997-11-06	Process for the control of pests
AU3973793A (en)	1993-11-29	Method of treating cancer
AUPM885294A0 (en)	1994-11-10	Chemically assisted protein annealing treatment
AU5713196A (en)	1996-11-07	Method for treatment of pain
AU4027097A (en)	1998-03-26	Method of treatment
AU7113996A (en)	1997-04-09	Methods of treating beta-amyloid-associated conditions
AU7156996A (en)	1997-04-01	Methods for treatment of interstitial cystitis
AU6358994A (en)	1994-09-26	Method of cancer treatment
AU1000795A (en)	1995-07-13	Moquitoe control method

Legal Events

Date	Code	Title	Description
2000-04-20	FGA	Letters patent sealed or granted (standard patent)